BIOMARIN PHARMACEUTICAL INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended September 30, 2024, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated the contracts, instructions or written plans for the purchase or sale of BioMarin securities as set forth in the table below.
| Type of Trading Arrangement | |||||||
|---|---|---|---|---|---|---|---|
| Name | Position | Action | Adoption/TerminationDate | Rule 10b5-1(1) | Non-Rule 10b5-1(2) | Total Shares of Common Stock to be Sold(3) | Expiration Date |
| Brian R. Mueller | Executive Vice President and Chief Financial Officer | Adoption | September 13, 2024 | X | up to 39,314 | August 29, 2025 | |
| Cristin M. Hubbard | Executive Vice President and Chief Commercial Officer | Adoption | September 13, 2024 | X | up to 6,022 and all of the ESPP shares to be acquired(4) | August 29, 2025 | |
(1) Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
(2) “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
(3) Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan.
(4) The Rule 10b5-1 trading arrangement for Ms. Hubbard provides for the sale of (i) up to 6,022 shares of our common stock underlying certain RSU awards and (ii) all of the shares of our common stock to be acquired under our Employee Stock Purchase Plan (ESPP). The number of shares to be acquired under the ESPP is indeterminable at this time as the purchase price for such shares will be determined at the end of the applicable purchase period under the ESPP.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.